Literature DB >> 29269560

Quantification of the Arrhythmogenic Effects of Spontaneous Atrial Extrasystole Using High-Resolution Epicardial Mapping.

Christophe P Teuwen1, Charles Kik1, Lisette J M E van der Does1, Eva A H Lanters1, Paul Knops1, Elisabeth M J P Mouws1, Ad J J C Bogers1, Natasja M S de Groot2.   

Abstract

BACKGROUND: Atrial extrasystoles (AES) can initiate atrial fibrillation. However, the impact of spontaneous AES on intra-atrial conduction is unknown. The aims of this study were to examine conduction disorders provoked by AES and to correlate these conduction differences with patient characteristics, mapping locations, and type of AES. METHODS AND
RESULTS: High-resolution epicardial mapping (electrodes N=128 or N=192; interelectrode distance, 2 mm) of the entire atrial surface was performed in patients (N=164; 69.5% male; age 67.2±10.5 years) undergoing open-chest cardiac surgery. AES were classified as premature, aberrant, or prematurely aberrant. Conduction delay and conduction block were quantified during sinus rhythm and AES and subsequently compared. Median incidence of conduction delay and conduction block during sinus rhythm was 1.2% (interquartile, 0%-2.3%) and 0.4% (interquartile, 0%-2.1%). In comparison, the median incidence of conduction delay and conduction block during 339 AES was respectively 2.8% (interquartile, 1.3%-4.6%) and 2.2% (interquartile, 0.3%-5.1%) and differed between the types of AES (prematurely aberrant>aberrant>premature). The degree of prematurity was not associated with a higher incidence of conduction disorders (P>0.05). In contrast, a higher degree of aberrancy was associated with a higher incidence of conduction disorders; AES emerging as epicardial breakthrough provoked most conduction disorders (P≥0.002). AES caused most conduction disorders in patients with diabetes mellitus and left atrial dilatation (P<0.05).
CONCLUSIONS: Intraoperative high-resolution epicardial mapping showed that conduction disorders are mainly provoked by prematurely aberrant AES, particularly in patients with left atrial dilation and diabetes mellitus or emerging as epicardial breakthrough.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation; dilatation; electrodes; epicardial mapping; incidence

Mesh:

Year:  2018        PMID: 29269560     DOI: 10.1161/CIRCEP.117.005745

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  6 in total

1.  Premature atrial stimulation accentuates conduction abnormalities in cardiac surgery patients that develop postoperative atrial fibrillation.

Authors:  Muhammad S Khan; Matthias Lange; Ravi Ranjan; Vikas Sharma; Jason P Glotzbach; Craig Selzman; Derek J Dosdall
Journal:  J Electrocardiol       Date:  2021-09-10       Impact factor: 1.380

2.  Does conduction heterogeneity determine the supervulnerable period after atrial fibrillation?

Authors:  Annejet Heida; Willemijn F B van der Does; Mathijs S van Schie; Lianne N van Staveren; Yannick J H J Taverne; Ad J J C Bogers; Natasja M S de Groot
Journal:  Med Biol Eng Comput       Date:  2022-10-12       Impact factor: 3.079

Review 3.  Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation.

Authors:  Mathijs S van Schie; Natasja Ms de Groot
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

4.  Editorial: Risk Stratification Strategies for Cardiac Rhythm Abnormalities.

Authors:  Gary Tse; Nan Zhang; Wenhua Song; Konstantinos P Letsas; Tachapong Ngarmukos; Kamalan Jeevaratnam; Tong Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-27

5.  Novel insights in pathophysiology of postoperative atrial fibrillation.

Authors:  Rohit K Kharbanda; Mathijs S van Schie; Yannick J H J Taverne; Natasja M S de Groot; Ad J J C Bogers
Journal:  JTCVS Open       Date:  2021-03-09

6.  Simultaneous Endo-Epicardial Mapping of the Human Right Atrium: Unraveling Atrial Excitation.

Authors:  Rohit K Kharbanda; Paul Knops; Lisette J M E van der Does; Charles Kik; Yannick J H J Taverne; Maarten C Roos-Serote; Annejet Heida; Frans B S Oei; Ad J J C Bogers; Natasja M S de Groot
Journal:  J Am Heart Assoc       Date:  2020-08-18       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.